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Department of Chemical and Biological Engineering, University of Wisconsin, Madison, WisconsinABSTRACT Expanded CAG diseases are progressive neurodegenerative disorders in which specific proteins have an unusu-
ally long polyglutamine stretch. Although these proteins share no other sequence or structural homologies, they all aggregate
into intracellular inclusions that are believed to be pathological. We sought to determine what impact the position and number of
glutamines have on the structure and aggregation of the host protein, apomyoglobin. Variable-length polyQ tracts were inserted
either into the loop between the C- and D-helices (QnCD) or at the N-terminus (QnNT). The QnCD mutants lost some a-helix and
gained unordered and/or b-sheet in a length-dependent manner. These mutants were partially unfolded and rapidly assembled
into soluble chain-like oligomers. In sharp contrast, the QnNT mutants largely retained wild-type tertiary structure but associated
into long, fibrillar aggregates. Control proteins with glycine-serine repeats (GS8CD and GS8NT) were produced. GS8CD
exhibited similar structural perturbations and aggregation characteristics to an analogously sized Q16CD, indicating that the
observed effects are independent of amino acid composition. In contrast to Q16NT, GS8NT did not form fibrillar aggregates.
Thus, soluble oligomers are produced through structural perturbation and do not require polyQ, whereas classic fibrils arise
from specific polyQ intermolecular interactions in the absence of misfolding.INTRODUCTIONThe expanded CAG repeat diseases consist of nine neurode-
generative disorders that are characterized by progressive
loss of motor function and eventually cognitive decline,
the most common of which is Huntington’s disease (1). In
affected individuals, a disease-specific protein is expressed
with an abnormally long polyglutamine (polyQ) domain.
The proteins share no other sequence or structural homology
(2). Nuclear and/or cytoplasmic aggregates of the polyQ
protein and/or its proteolytic fragments are invariably
present in the disease state (3). These protein aggregates
are hypothesized to cause neurodegeneration, although the
mechanism for toxicity remains elusive. Two leading theo-
ries suggest that sequestration of transcription factors into
aggregates (4,5) or overload of the ubiquitin-proteosomal
system (6) may play a role.
The length of the expanded polyQ domain is inversely
correlated with the age of onset of symptoms. The correla-
tion is striking enough that it is common to describe a
threshold length for disease, which varies from ~20 to ~60
glutamines depending on the specific disorder (1). Both
the length of the polyQ domain (7–10) and its context within
the protein (11–14) influence the propensity for aggregation.
Some investigators have argued that destabilization of the
native protein structure by expanded polyQ drives aggrega-
tion (15–17). Others have reported that increasing the polyQ
length does not further destabilize the protein but still
enhances aggregation (18), which would argue for the domi-
nant role of polyQ-specific intermolecular association.Submitted January 7, 2011, and accepted for publication April 8, 2011.
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0006-3495/11/06/2773/10 $2.00Simulations suggest that the folding/unfolding transition
broadens with polyQ length, increasing the lifetime of
partially folded, aggregation-prone intermediates (19).
We set out to conduct a systematic study of the relative
importance of the length of the polyQ domain, and the
context into which the domain is placed, in terms of mis-
folding and aggregation. The ideal host protein for such
biophysical studies is readily expressed, purified, and folded,
and has well-characterized structural features. Unfortu-
nately, in general, the proteins that are associated with
expanded CAG diseases do not meet these criteria. With a
few exceptions, little is known about their native structure
or folding pathways, and many are difficult to express
recombinantly as full-length proteins or without fusing to
a solubilizing protein (2,3). We therefore chose to conduct
our studies using a host protein that is not associated
with disease. Precedence for this approach was established
by previous studies that used glutathione S-transferase
(20–22), thioredoxin (23,24), CRABP1 (8,17), Staphylo-
coccal protein A (14), and Sup35 (25). This approach is
also justified biologically by experiments wherein symptoms
of classic polyQ neurodegenerative disease were induced by
incorporation of expanded polyQ domains into an otherwise
innocuous protein (26).
We chose to use apomyoglobin as our host protein for
several reasons. First, apomyoglobin is readily expressed
in Escherichia coli, and a wealth of information on its
solution structure, stability, and folding pathway is available
(27–30). Second, the native fold contains a-helices and
a significant amount of disorder, reflecting the major
secondary structural elements of the CAG-disease-related
proteins (31–34). Third, we speculated that a marginally
stable protein like apomyoglobin (28) would serve as a betterdoi: 10.1016/j.bpj.2011.04.028
2774 Tobelmann and Murphymodel of amyloidogenic polyQ-containing proteins because
the disease-related proteins are relatively unstable (15,35)
and may populate multiple folds (36). Finally, others have
used myoglobin as a model for amyloidogenic proteins
(37–39) and as a host protein for polyQ (9,40,41).
We generated a small library of apomyoglobin mutants
with variable polyQ length and position. Two positions
were selected: the flexible surface loop between the short C
and D helices (QnCD, where n ¼ number of glutamines),
and the N-terminus (QnNT). The mutants contained eight to
46 glutamines (Fig. 1). Unique to our work (to our knowl-
edge), we created control mutants containing a glycine-
serine repeat (GS8) in place of polyQ, to assist in decoupling
contributions of structural perturbation to aggregation from
specific polyQ-driven interactions. We then probed changes
in secondary and tertiary structure, as well as the aggregation
kinetics and aggregate morphology.MATERIALS AND METHODS
Protein production and purification
We generated most of the QnCD mutants using a previously described
procedure (42). For Q8CD, GS8CD, Q8NT, Q16NT, Q32NT, and GS8NT,
recombinant proteins were expressed as described in the Supporting
Material. Protein was recovered from the cell lysate supernatant and puri-
fied by nickel affinity chromatography. The proteins were refolded by rapid
dilution, concentrated by ultrafiltration, and further purified by size exclu-
sion chromatography (SEC; see Supporting Material). Unless otherwise
specified, freshly concentrated protein samples in citrate buffer were imme-
diately filtered with a 0.45 mM polyvinylidene fluoride filter, and the
concentration was adjusted to ~6–10 mM.N-terminus
CD loop
            D45 R46 F47 K48NH2 COOH
6x-His
Qn
Qn-CD
M1     V2NH2 COOH
6x-His
Qn
Qn-NT
FIGURE 1 Myoglobin crystal structure and mutation sites (PDB ID
1MBN). In the apo form, the F-helix is unstructured. For QnCD, Qn was
inserted between D45 and K48, deleting R46 and F47. For QnNT, Qn was
inserted between M1 and V2.
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Freshly concentrated protein samples were prepared in 10 mM sodium
phosphate, pH 6.8. Circular dichroism (CD) spectra were collected on an
Aviv 202SF CD spectrometer at 20C. The spectra were fit to a reference
set (SP37), and secondary structure was calculated using the CONTINLL
algorithm in CDPRO.Fluorescence spectroscopy
Tryptophan fluorescence emission spectra were obtained with a
QuantaMaster Series spectrofluorometer (PTI, Birmingham, NJ), with exci-
tation at 295 nm. The center of spectral mass (lCSM) was calculated as
described previously (44). A stock solution of 8-anilino-1-naphthalene
sulfonic acid (ANS, 800 mM; AnaSpec, San Jose, CA) was diluted
10-fold with sample to yield an ANS/protein ratio of 8:1. Fluorescence
spectra were obtained with excitation at 350 nm, and ANS lCSM was calcu-
lated using emission spectra from 410 to 500 nm. Unfolding in urea was
followed by Trp fluorescence as described in the Supporting Material.Monomer loss and sedimentation kinetics
Freshly prepared samples were injected onto a Superdex 75 PC 3.2/30 size
exclusion column (GE Healthcare, Piscataway, NJ). Detection was made by
absorbance at 280 nm and peak area was obtained by integration; the mean
error was 4.5%. Samples were aliquoted into low-retention microcentrifuge
tubes (Fisher, Pittsburgh, PA), sealed with paraffin film, and incubated at
37C. At regular intervals, a sample tube was withdrawn and centrifuged
at 19,500 rcf for 30 min. The supernatant (top 75%) was removed and sub-
jected to SEC analysis. To determine the fraction of soluble protein, we
determined the mass concentration in the supernatant in triplicate with a
bicinchoninic acid (Pierce, Rockford IL) assay, using a BioTek (Winooski,
VT) EL 800 Universal Microplate Reader.Transmission electron microscopy
For transmission electron microscopy (TEM), samples were incubated at
37C for ~3 weeks. A drop was applied to a pioloform-coated grid, stained
with methylamine tungstate stain, and then imaged with a Philips CM120
scanning transmission electron microscope (Philips, FEI, Hillsboro, OR).RESULTS AND DISCUSSION
Protein production, refolding, and purification
Qualitatively, the yield of protein was lower for the QnCD
mutants than for the wild-type (WT), and yields decreased
noticeably as the length of the polyQ domain increased. In
contrast, yields of QnNT were at least as good as that of
WT, and there was no drop-off in yield with polyQ length.
WT spontaneously refolded to monomers after rapid dilu-
tion from denaturing buffer, but a small peak eluting at
higher molecular weight was detected (Fig. S1), consistent
with published results and attributed to nonnative aggrega-
tion during refolding (38). Similar peaks were detected
for all QnCD mutants, with the fraction increasing signifi-
cantly with increasing polyQ length. No high-molecular-
weight peaks were observed for any QnNT mutants.
Others have reported considerable difficulties in expressing
folded and soluble polyQ-containing proteins (14,31,45).
Our data illustrate that expression and refolding are strongly
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FIGURE 2 Change in the number of residues in secondary structural
elements, relative to WT. The fraction of each secondary structure element
was determined as described, and then multiplied by the total number of
residues in each protein to calculate the number of residues of that element
in the protein. This number was compared with the calculated average
number of WT residues (n ¼ 5) in that secondary structural element. Error
bars represent the maximum and minimum of two independent measure-
ments, with the exception of Q16CD (95% confidence interval) and
Q34CD (three independent measurements).
Location versus Length in PolyQ Proteins 2775dependent on polyQ context. Positioning the domain in
the CD loop significantly reduced both protein expression
and efficient refolding in a length-dependent manner,
whereas placing the domain N-terminally enhanced efficient
refolding.
The monomer fraction was isolated and concentrated
before further characterization. Most preparations remained
fully monomeric after concentration, although for a few
QnCD mutants we observed small oligomer peaks even after
SEC purification. Most preparations were at least ~95%
pure by sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (not shown). For the longest QnCD mutants, we
observed some protein contaminants after SEC purification
and concentration, identified by mass spectrometry as
E. coli ribosomal proteins. The purity of these contaminated
samples is estimated at ~85%. The residual heme content
was assayed as 2% in WT and ~0.5% in all of the QnCD
mutants. The heme content of QnNT was a weak function
of length, with 0.7% in Q8NT, 1% in Q16NT, and 2.5% in
Q32NT.
Tanaka et al. (9,40,41) created myoglobin mutants with
polyQ sequences of various lengths inserted into the CD
loop. Their system differs from our QnCDmutants in several
ways: 1), their insert included 16 residues from ataxin-3; 2),
they did not specifically report removal of oligomers
that could have formed during purification (9); and 3), their
proteins contained variable amounts of heme (9,41).We took
care to ensure that little to no heme remained, because holo-
myoglobin is more stable and considerably more resistant to
aggregation than is apomyoglobin (46), and any variability in
heme content would have complicated interpretation of our
results.Effects of polyQ location and length on
secondary structure
CD spectra were collected for WTand all mutants (Fig. S2).
The WT spectra exhibited minima at 209 nm and 222 nm,
indicative of a predominantly a-helical protein. There was
slight deepening of these minima with QnNT. In contrast,
with QnCD, there was a length-dependent flattening of these
minima as well as a decrease in the maximum at 194 nm.We
estimated the distribution of secondary structural elements
by quantitative analysis of CD spectra. The fitted values
for WT agreed well with solution structures obtained from
NMR (28,29). We calculated the number of residues in
each secondary structure element by multiplying the frac-
tion of that element by the total number of residues in that
mutant, and then calculated the change in the number of
residues adopting each secondary structure relative to WT
(Fig. 2).
With QnNT, there was a modest increase in the calculated
number of helical residues compared with WT, but little
change in b-sheet or disorder. These data suggest that the
added glutamine residues may adopt a partially a-helicalconformation when placed at the N-terminus. Alternatively,
it is possible that the addition of polyQ at the N-terminus
increases the helical content of the protein core, but this
seems less likely.
Significantly different effects were obtained with QnCD,
and these effects were length-dependent. For Q8CD, there
was no change in a-helix or b-sheet, and the increase in
the number of disordered residues was the same as the
increase in the total number of residues. The simplest inter-
pretation is that the native secondary structure of apomyo-
globin is not disturbed and the Q8 sequence is disordered.
With intermediate-length mutants (n ¼ 16–28), there was
a loss of a-helix, a slight increase in b-sheet, and a larger
increase in disordered residues. We hypothesize that inser-
tion of Q16 to Q28 in the CD loop results in unwinding of
the short adjacent helices (four and five residues, respec-
tively). As the polyQ length increased further (n ¼ 34–46),
the loss of helical residues remained about the same, but
there was a larger increase in the number of b-sheet resi-
dues. A reasonable interpretation of these data is that the
polyQ insert along with the flanking residues adopts some
b-sheet character as the insert becomes longer. These exper-
iments do not allow us to determine whether the additional
b-sheet content is restricted to the erstwhile helices of the
host protein or to the inserted polyQ sequence. Overall,
there was not a sharp demarcation but rather a gradual tran-
sition in secondary structure between shorter and longer
polyQ domains.
Our results can be usefully compared with literature
reports. Bevivino and Loll (15) reported a loss in a-helixBiophysical Journal 100(11) 2773–2782
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2776 Tobelmann and Murphyand increase in random coil with an increase in Q length in
ataxin-3. PolyQ fused to glutathione-S-transferase was flex-
ible and disordered independent of length (20,22). Similarly,
polyQ fused to the C-terminus of Staphylococcal aureus
protein A (SpA) B domain was disordered independent
of length, and there was no effect on the conformation of
the host protein (14). Nagai et al. (23) fused polyQ to the
C-terminus of thioredoxin, a b-sheet protein, and observed
increased helical content in a Q-length-dependent manner.
In the huntingtin exon 1 fragment, Q17 adopted a heteroge-
neous mix of conformations, including a-helix, extended
loop, and disordered (47). Modest increases in helical
content due to polyQ have been reported for an androgen
receptor fragment (48) and myoglobin mutants (41). These
results illustrate that polyQ conformation is strongly
context-dependent, and polyQ is almost universally either
disordered or a-helical.15000
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FIGURE 3 Trp fluorescence spectroscopy. All data points are the average
of two experiments, with the exception of Q20CD, Q24CD, Q34CD, and
Q38CD, for which three independent experiments were performed. Error
bars represent the maximum and minimum values measured. (A) Center-
of-spectral-mass wavelength, calculated using emissions from 320 to
360 nm. (B) Fluorescence emission intensity at maximum wavelength.Effects of polyQ location and length on tertiary
fold and stability
Apomyoglobin contains two tryptophans, W7 and W14,
both of which are within the N-terminal helix. W14 contrib-
utes most to the fluorescence emission intensity because W7
fluorescence is quenched in the natively folded protein. W7
is partially solvent-exposed, and W14 is in a predominantly
hydrophobic environment (49).
For all QnNT mutants, Trp lCSM was blue-shifted slightly
relative toWT (Fig. 3A), suggesting partial burial ofW7 into
a more hydrophobic environment. In contrast, for QnCD,
lCSM was red-shifted, indicative of increased exposure to
a polar environment and partial loss of native tertiary struc-
ture (41). For both QnCD and QnNT, emission intensity was
Q-length-dependent (Fig. 3B). Emission intensity was great-
est for the mutants with the shortest polyQ length, and then
decreased as the Q length increased. The emission intensity
of Q46CD was well below that of WT. One possible explana-
tion for the length-dependent loss of Trp emission intensity
is increased quenching with glutamine (50), as this loop
becomes long enough to interact with the N-terminal helix.
To further assist in interpreting these data, we partially
unfolded WT in urea. At 2.5 M urea (20% unfolded), WT
exhibited a red shift and an increase in Trp emission inten-
sity (not shown) that was very similar to that observed for
Q8CD, Q16CD, and Q20CD in the absence of urea. This
suggests that the polyQ domain inserted into the CD loop
causes partial (~20%) unfolding of apomyoglobin. If WT
is unfolded further by increasing the urea concentration,
Trp lCSM and intensity both increase further (not shown).
This is not what we observed with increasing Q length, sug-
gesting that although the polyQ insert triggers partial loss of
tertiary structure, lengthening the polyQ domain does not
push the protein toward more unfolding.
Unfolding of the mutants during urea denaturation was
studied by monitoring Trp fluorescence. QnNT mutantsBiophysical Journal 100(11) 2773–2782were slightly more resistant to unfolding than WT as
measured by the increased concentration of urea (þ0.4M)
required for 50% unfolding (Cm). In contrast, QnCDmutants
were less resistant to unfolding than WT (Cm decreased by
0.6 M). There was little or no polyQ length-dependent effect
on Cm (Fig. S3). The unfolding curve was broader for QnCD
than for WT or QnNT mutants (Fig. S4). This is suggestive
of less sharply defined transitions for QnCD along the
unfolding pathway and the presence of a conformational
ensemble rather than a single native fold, consistent with
simulations (19).
ANS binds strongly to the hydrophobic heme pocket of
apomyoglobin (51), and its fluorescence can be used to
confirm the existence of the pocket, which forms only
upon attainment of the correct tertiary fold. ANS also
detects hydrophobic patches that are exposed when a protein
partially unfolds. ANS emission maximum at 455 nm and
strong fluorescence intensity confirmed formation of the
heme pocket for WT (not shown). All of the QnNT mutants
Location versus Length in PolyQ Proteins 2777retained the ANS spectra of WT, indicating that addition of
polyQ to the N-terminus did not interfere with formation of
the pocket (Fig. 4). In contrast, the ANS fluorescence wave-
length was markedly red-shifted for all QnCD independently
of Q length (Fig. 4 A), and the emission intensity was
measurably decreased in a weakly length-dependent manner
(Fig. 4 B). This result demonstrates loss of the heme pocket
in QnCD. The decrease in ANS fluorescence with increasing
Q length suggests that the hydrophobic patches exposed by
partial unfolding are lost, either because of further unfolding
or because these patches are covered by the long polyQ
segment, as suggested by simulations (52). The changes in
ANS fluorescence upon introduction of residues to the CD
loop are very similar to those seen in WT upon partial
unfolding with 2.5 M urea (not shown). We conclude that
QnCD suffers partial loss of tertiary structure relative to
WT, whereas native tertiary structure is retained in QnNT.
Several other groups observed changes in tertiary struc-
ture or stability with polyQ proteins in previous studies,455
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FIGURE 4 ANS fluorescence spectroscopy. All data points represent the
average of two experiments, with the exception of Q34CD, for which three
independent measurements were collected. Error bars represent the
maximum and minimum values measured. (A) Center-of-spectral-mass
wavelength, calculated using emission spectra from 410 to 500 nm. (B)
Fluorescence emission intensity at maximum wavelength.and most reported a decrease in stability. Robertson et al.
(14) observed a large decrease in stability, in a Q-length-
independent manner, when the polyQ domain was placed
in a loop between two helices in the SpA B domain.
However, they were unable to produce proteins with an inte-
rior sequence longer than 25 glutamines, and thus (in
contrast to our study) did not probe the aggregation proper-
ties of these proteins. A partial loss of tertiary structure and/
or a decrease in chemical or thermal stability with polyQ-
containing proteins was also observed in studies involving
CRABP I-httexon1 fusion proteins (8) and ataxin-3 (15,18).
Several studies reported no effect of polyQ on stability
(14,22). We are aware of only one study in which polyQ
increased stability (measured as an increase in the tempera-
ture required to induce aggregation), with C-terminal attach-
ment to glutathione S-transferase (21). We conclude that
polyQ is more readily accommodated by a host protein if
it is placed on the terminus rather than in a spatially
restricted area, such as an interior loop.Non-polyQ-specific changes in secondary
and tertiary structure
To test whether any sequence inserted into the CD loop
would cause a structural perturbation, we produced a mutant
containing a GlySer octet repeat, GS8CD. We chose to use
glycine and serine because they are flexible, hydrophilic
residues that are frequently found in disordered loops at
protein surfaces (53). We analyzed CD spectra, Trp and
ANS fluorescence spectra, and urea denaturation curves
for GS8CD and compared the data with those obtained
from the two mutants with inserts of identical length,
Q16CD and Q16NT (Table 1). Changes in secondary and
tertiary fold for GS8CD and Q16CD relative to WT were
very similar, and quite distinct from the (smaller) changes
with Q16NT. These data demonstrate that the partial loss
of structure observed in the QnCD mutants does not specif-
ically require polyQ.Monomer loss and sedimentation
TheWT, three QnCD mutants (n¼ 8, 16, or 38), three QnNT
mutants (n ¼ 8, 16, or 32), and controls GS8CD and GS8NT
were selected for aggregation studies. Samples were moni-
tored for monomer loss and soluble oligomer formationTABLE 1 Secondary and tertiary structure changes with 16-
mer insert, relative to WT
Change in number
of residues
Change in
lCSM (nm)
Change in
[Urea] (M)
a-helix b-sheet coil/turn Trp ANS at 50% unfolding
Q16-NT þ7 þ4 þ6 0.25 þ0.8 þ0.5
Q16-CD 13 þ10 þ18 þ0.49 þ6.2 0.6
GS8-CD 8 þ7 þ15 þ0.34 þ5.6 0.4
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2778 Tobelmann and Murphyby SEC, and for formation of insoluble aggregates by
sedimentation.
Representative chromatograms are shown in Fig. 5. No
monomer loss was observed for WT over the 4-week test
period (Fig. 5 A). In contrast, for QnCD, rapid monomer
loss was indicated by a decrease in the monomer peak,
which coincided with the appearance of an oligomeric
peak eluting at the void volume (70 kDa). For Q16CD
(Fig. 5 B), the monomer peak gradually disappeared while
the oligomer peak gradually increased, whereas for Q8CD
(Fig. 5 D), the monomer peak disappeared and the oligomer
peak appeared within 24 h, followed by a slow loss of olig-
omer. For all QnCD mutants, the monomer loss kinetics was
biphasic, with a rapid initial loss followed by a slowerFIGURE 5 Size-exclusion chromatograms as a function of time. Curves
from bottom to top represent chromatographs for injections at 0, 2, 7, 14,
21, and 28 days. (A) WT. (B) Q16CD; no data at 28 days. (C) Q8NT chro-
matographs (inset: magnification of the soluble oligomer peak); no data at
zero days. (D) Q8CD; no data at 21 days.
Biophysical Journal 100(11) 2773–2782decline (Fig. 6 A). Surprisingly, monomer loss did not
monotonically increase with Q length. The greatest mono-
mer loss was observed for the shortest mutant, Q8CD.
The loss of soluble protein, as measured by sedimenta-
tion, lagged considerably behind the loss of monomer as
detected by SEC (Fig. 6 B). Consistent with the monomer-
loss data, the greatest sedimentation was observed with
Q8CD. After 4 weeks, only 40% of Q8CD remained soluble,
compared with 80% of Q38CD and 90% or more for all other
mutants. The difference between the monomer-loss and
sedimentation kinetics can be attributed to the formation
of soluble aggregates.
Partially unfolded WTapomyoglobin is prone to aggrega-
tion (38); therefore, we propose that aggregation of QnCD is
directly linked to partial loss of native fold. With Q8CD
there was no loss of native secondary structure, but there0
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FIGURE 6 Aggregation kinetics. Samples were simultaneously analyzed
for monomer loss and sedimentation: Q8CD (-), Q16CD (:),Q38CD (C),
Q8NT (,), Q16NT (6), Q32NT (B), GS8CD (), and GS8NT (þ). Solid
lines: Qn-CD and Qn-NT; dashed lines: GS8 controls. (A) Monomer loss as
a fraction of the initial monomer peak area. Initial monomer peak areas are
an average of peak areas calculated from three injections. Peak areas for
days 1–5 were calculated from single injections. Peak areas for days 7,
14, 21, and 28 are averages of two injections. Error bars from multiple
injections were insignificant (<1.5%) and are not shown. (B) Sedimentation
kinetics data. All data points are averages of three measurements. Error bars
were small and are not shown for clarity.
Location versus Length in PolyQ Proteins 2779was partial loss of tertiary structure and surprisingly aggres-
sive aggregation. We hypothesize that in Q8CD, rapid
aggregation is driven by exposure of hydrophobic patches
due to partial loss of tertiary fold. With Q16CD there was
a net loss of native helix, and rapid initial association into
oligomers, but little sedimentation. The lower sedimentation
with Q16CD compared with Q8CD could be due to the loss
of helix. It is possible that the unwinding of the C- and
D-helices provides sufficient additional entropy to maintain
the oligomers in a soluble state. These data are usefully
compared with literature reports of greater unfolding and
decreased aggregation of apomyoglobin with increasing
temperature (37,54). Thus, inserting Q8 or Q16 into the CD
loop appears to be functionally equivalent to increasing the
temperature. As the Q length increased further to 38, the
loss of native helix was accompanied by increased nonnative
refolding to b-sheet. We hypothesize that this refolding may
explain why sedimentation is detected with Q38CD but not
with Q16CD. The monomer-loss and sedimentation kinetics
for the control mutant, GS8CD, was very similar to that
of its Q16 cousin (Fig. 6). This result demonstrates that
partial unfolding and aggregation in the CD mutants is
driven by the structural perturbation brought about by the
insertion, and does not require specific intermolecular polyQ
association.
For QnNT, the monomer peak area was largely constant
over time (Fig. 5 C). However, close examination revealed
the existence of a very small oligomer peak at the void that
appeared only after several days (Fig. 5 C, inset). In contrast
to the rapid initial loss of monomer with the QnCD mutants,
there was an apparent lag period before the onset of modest
monomer loss for QnNT (Fig. 6 A). Despite the retention of
secondary and tertiary structure, the QnNT mutants experi-
enced some monomer loss, whereas the WT did not. Very
little sedimentation was measured (Fig. 6 B).Aggregate morphology
No aggregates were observed in TEM images of freshly
preparedWTormutants, or for agedWT, across several fields
of view (not shown). With QnCD aged for 3 weeks at 37
C,
we observed numerous small, flexible, chainlike aggregates,
100–200 nm in length, as well as some annular aggregates
(Fig. 7, A, B, and D). These QnCD aggregates have a fuzzy,
beads-on-a-string appearance, and such aggregates are
frequently termed protofibrils. Of interest, these aggregates
are morphologically very similar in length, diameter, and
flexibility to those obtained by thermal denaturation of apo-
myoglobin (54). ForQ8CD andQ38CD, oligomers eventually
coalesced to form larger, amorphous aggregates (not shown),
which likely accounts for the material lost by sedimentation
(Fig. 6 B). Aggregates of GS8CD closely resembled those of
the QnCD proteins (Fig. 7 C). This follows the pattern of all
other assays inwhich theGS8CD control exhibited properties
very similar to those of Q16CD.With aged QnNT, we observed aggregates of starkly
different morphology.With Q8NTandQ16NT, we saw highly
ordered rigid fibrils, several microns in length and ~25 nm in
width, that appeared to be bundles of aligned filaments with
a twisted morphology (Fig. 7, E and F). The fibrils were
sparse, and we had to examine many fields of view to detect
them. Q32NT aggregates were much more abundant than
Q8NT and Q16NT aggregates, and tended to be somewhat
shorter (Fig. 7 G). These aggregates were frequently assem-
bled into a filamentous network (Fig. 7G, inset) very similar
in appearance to that formed from TBP-Q38 (55). Together
with the observation that no oligomers were apparent
in QnNT until after a lag period of several days (Figs. 5 C
and 6 C), these results suggest that QnNT, unlike QnCD,
self-associates via a classic nucleation-elongation pathway.
We hypothesize that the ratio of nucleation/elongation rate
constants increases with increasing polyQ length: slow
(rare) nucleation leads to fewer, longer aggregates (as in
Q8NTor Q16NT), whereas faster (more frequent) nucleation
results in more, shorter aggregates (as in Q32NT). We specu-
late that the lower number density of Q8NT and Q16NT
facilitates diffusion and alignment of filaments into fibrillar
bundles in an orderly fashion, whereas the more numerous
Q32NT filaments become kinetically trapped in a loose
network because of crowding. We also examined the
morphology of aged GS8NT. Strikingly absent from these
TEM images is the presence of any fibrils. However, some
short, semiflexible aggregates, similar in size and shape to
those of the GS8CD and QnCD aggregates, can be observed
(Fig. 7 H).
We hypothesize that the morphological differences
between QnCD and QnNT aggregates arise from differences
in the driving force for aggregation. Specifically, protofibrils
arise from rapid association of partially misfolded protein
via exposed hydrophobic patches. Because we saw virtually
identical structural perturbations, aggregation kinetics, and
aggregate morphology with Q16CD and GS8CD, we con-
clude that oligomerization is independent of the amino
acid composition of the insert. In contrast, QnNT fibrils arise
not from partial unfolding or misfolding but from specific
polyQ-mediated intermolecular interactions. This conclu-
sion is supported by the observation that the QnNT mutants
were at least as stable as the WT, which does not aggregate,
and GS8NT did not form fibrils.
Our data suggest that nonspecific partial loss of native
structure leads to protofibrils, whereas polyQ-mediated
association produces classic fibrils. There is some support
in the literature for this notion. Some groups have reported
that ataxin-3 with expanded polyQ is destabilized and
quickly aggregates into chains similar in appearance and
dimensions to those we observed for QnCD (15,56,57).
Other researchers observed no destabilization of ataxin-3
with polyQ expansion, and aggregation into long fibrils of
20–45 nm diameter, similar in appearance to our QnNT
fibrils (18). Ignatova and Gierasch (8) and Ignatova et al.Biophysical Journal 100(11) 2773–2782
FIGURE 7 TEM images taken after incubation at 37C for ~3 weeks, except for GS8NT, which was incubated for ~2 months. All images are representative
of several fields of view. Reference bars are 200 nm. (A) Q8CD. (B) Q16CD. (C) GS8CD. (D) Q38CD. (E) Q8NT. (F) Q16NT. (G) Q32NT (inset: Q32NT fila-
mentous network). (H) GS8NT.
2780 Tobelmann and Murphy(17) observed a shift in the aggregate morphology of
a CRABP I-httexon1 chimera over time from spherical to
curvilinear to fibrillar. They suggested that aggregation is
initially driven by the aggregation-prone CRABP I domain
but then later is dominated by the polyQ domain. This
conclusion is similar to those reached by Bulone et al.
(21) in their study of GST-polyQ fusion proteins, and by
Ellisdon et al. (16,57). Both chain-like oligomers and
ordered fibrils have been observed with huntingtin exon 1
fragments (58–60), with the more tightly packed, fibrillar
aggregates dominating as the length of the polyQ domain
increased (59,60).CONCLUSIONS
We conducted a systematic investigation of folding and
aggregation in polyQ-containing proteins. We produced a
library of proteins with polyQ lengths ranging from sub- toBiophysical Journal 100(11) 2773–2782suprapathological, and with inserts at two positions: the
N-terminus and an interior loop. Of importance, we
included two control mutants so that we could differentiate
between the generic effects of insertion and specific polyQ
effects. To our knowledge, no other studies of polyQ-medi-
ated protein misfolding and aggregation have included these
kinds of controls.
The location of the polyQ domain had a dominant influ-
ence on the nature of the effect of the insert on protein
folding and aggregation, whereas the length of the domain
modulated the extent of these effects. One of our most
striking findings is the difference in morphology between
aggregates made from QnCD versus QnNT. Our data suggest
that, when placed in an interior loop, polyQ destabilizes
native structure and accelerates aggregation primarily
through partially folded intermediates and not through
specific polyQ-polyQ association. In contrast, polyQ placed
at the N-terminal site does not disturb the native structure
Location versus Length in PolyQ Proteins 2781but drives assembly into ordered fibrils through specific
polyQ-mediated association.
We propose that there are two modes of aggregation of
polyQ-containing proteins. One mode, epitomized by the
QnCD mutants, is driven by hydrophobic interaction caused
by destabilization and partial loss of native fold, leading to
protofibrils and other oligomers. The initial aggregation
kinetics is rapid, and, of importance, aggregation does not
specifically require glutamines. In the other mode, epito-
mized by the QnNT mutants, association into filaments
and fibrils follows classic nucleation-elongation kinetics
and requires specific polyQ intermolecular interactions. We
speculate that the second mode is operable only when polyQ
is in a less-restricted location, e.g., at the terminus or in
a highly flexible segment. In this light, it is interesting to
note the strong bias toward placement of repeat amino acid
motifs in disease-related proteins near the N- or C-terminus
(61,62) and/or in highly disordered segments (34). There
is growing evidence that aggregate morphology directs
toxicity, although the specific morphology required for
toxicity remains a matter of debate (23,59,63). Thanks to
their distinct and controllable conformational and aggrega-
tion properties, the mutants we created may prove to be
useful tools for teasing out the morphology-toxicity linkage.SUPPORTING MATERIAL
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biophysj.org/biophysj/supplemental/S0006-3495(11)00473-5.
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